feed,title,long_url,short_url
BioRxiv,Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance,https://biorxiv.org/cgi/content/short/2024.09.13.613000v1?rss=1,https://da.gd/4Yiwep
